New Incentives In Drug Development Needed For Superbugs, Acting FDA Chief Says

Bloomberg Law (5/5, Baumann, Subscription Publication) reports, “New incentives in drug development would help bring more affordable medicines to market, including those to combat antimicrobial resistance, FDA acting commissioner Janet Woodcock said Wedne...